BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23160184)

  • 1. A retrospective evaluation of radiotherapy for the treatment of local esophageal squamous cell carcinoma recurrence after initial complete surgical resection.
    Zhu YL; Li Q; Gao JM; Li JS; He ZY; Xu JJ; Lu XJ; Liu YM
    J Investig Med; 2013 Jan; 61(1):34-9. PubMed ID: 23160184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.
    Lertbutsayanukul C; Tharavej C; Klaikeaw N; Prayongrat A; Lowanitchai C; Sriuranpong V
    Thorac Cancer; 2017 May; 8(3):219-228. PubMed ID: 28322515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
    Xu X; Wang Z; Jiang S; Shang Y; Wu Y
    Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma.
    Chen SB; Weng HR; Wang G; Liu DT; Li H; Zhang H; Chen YP
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):277-86. PubMed ID: 26328915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive impact of radiation dose on disease free survival and locoregional control in postoperative radiotherapy for squamous cell carcinoma of esophagus.
    Moon S; Kim H; Chie E; Kim J; Park C
    Dis Esophagus; 2009; 22(4):298-304. PubMed ID: 19021683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience.
    Wang S; Liao Z; Chen Y; Chang JY; Jeter M; Guerrero T; Ajani J; Phan A; Swisher S; Allen P; Cox JD; Komaki R
    J Thorac Oncol; 2006 Mar; 1(3):252-9. PubMed ID: 17409865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A re-irradiation dose of 55-60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy.
    Wu X; Hu X; Chen J; He L
    Radiat Oncol; 2021 Jun; 16(1):100. PubMed ID: 34103059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
    Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
    Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: A single institution experience.
    Xu Y; Wang Z; Liu G; Zheng X; Wang Y; Feng W; Lai X; Zhou X; Li P; Ma H; Wang J; Hu X; Chen M
    J Cancer Res Ther; 2016 Oct; 12(Supplement):82-88. PubMed ID: 27721262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas.
    Miyata H; Yamasaki M; Kurokawa Y; Takiguchi S; Nakajima K; Fujiwara Y; Konishi K; Mori M; Doki Y
    Ann Surg Oncol; 2011 Nov; 18(12):3353-61. PubMed ID: 21537861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma.
    Lu JC; Kong C; Tao H
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):710-4. PubMed ID: 20172661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.
    Hisano O; Nonoshita T; Hirata H; Sasaki T; Watanabe H; Wakiyama H; Ono M; Ohga S; Honda H
    Radiat Oncol; 2018 Jan; 13(1):14. PubMed ID: 29378603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary mucoepidermoid carcinoma of the esophagus.
    Chen S; Chen Y; Yang J; Yang W; Weng H; Li H; Liu D
    J Thorac Oncol; 2011 Aug; 6(8):1426-31. PubMed ID: 21587086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Yano T; Muto M; Hattori S; Minashi K; Onozawa M; Nihei K; Ishikura S; Ohtsu A; Yoshida S
    Endoscopy; 2008 Sep; 40(9):717-21. PubMed ID: 18773340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes from chemoradiotherapy for patients with esophageal cancer.
    Pantling AZ; Gossage JA; Mamidanna R; Newman G; Robinson A; Manifold DK; Hale PC
    Dis Esophagus; 2011 Apr; 24(3):172-6. PubMed ID: 21073614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.
    Ren Y; Su C; Zhou Y; Zhao X; Yang CL; Liu YY
    World J Gastroenterol; 2014 Dec; 20(47):17970-5. PubMed ID: 25548496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma.
    Kang CH; Hwang Y; Lee HJ; Park IK; Kim YT
    Ann Thorac Surg; 2016 Oct; 102(4):1074-80. PubMed ID: 27302078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma.
    Sakanaka K; Ishida Y; Fujii K; Itasaka S; Miyamoto S; Horimatsu T; Muto M; Mizowaki T
    Radiat Oncol; 2018 Jan; 13(1):7. PubMed ID: 29347960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study.
    Deng W; Yang J; Ni W; Li C; Chang X; Han W; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Deng L; Wang W; Bi N; Zhang T; Li Y; Gao S; Xue Q; Mao Y; Sun K; Liu X; Fang D; Wang D; Li J; Zhao J; Shao K; Li Z; Chen X; Han L; Wang L; He J; Xiao Z
    Oncologist; 2020 Apr; 25(4):e701-e708. PubMed ID: 32083766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.